CWM
DMAC icon

Cornerstone Wealth Management’s DiaMedica Therapeutics DMAC Stock Holding History

Cornerstone Wealth Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Hold
16,250
– – ﹤0.01% 729
2026
Q1 		$110K Hold
16,250
– – 0.01% 694
2025
Q4 		$129K Hold
16,250
– – 0.01% 674
2025
Q3 		$112K Hold
16,250
– – 0.01% 667
2025
Q2 		$63.4K Hold
16,250
– – ﹤0.01% 641
2025
Q1 		$61.6K Buy
+16,250
New +$92.9K ﹤0.01% 597

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cornerstone Wealth Management's DMAC Position: Q2 2026 in Review

Cornerstone Wealth Management held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 16,250 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Cornerstone Wealth Management first reported a position in DMAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $129K in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • Cornerstone Wealth Management held 16,250 shares of DiaMedica Therapeutics worth $114K as of Q2 2026.
  • Cornerstone Wealth Management left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of Cornerstone Wealth Management's portfolio in Q2 2026, its #729 holding.
  • Cornerstone Wealth Management first reported a position in DiaMedica Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Cornerstone Wealth Management's DiaMedica Therapeutics position peaked at $129K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.